Poland· PL-100350300

Dynexan

A lidocaine product containing lidocaini hydrochloridum, registered in Poland by Chemische Fabrik Kreussler Co.GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC N01BB02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDynexanATCN01BB02REGISTER NO.PL-100350300PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Lidocaine is registered in 11 of 19 countries.

Countries holding a registration under ATC N01BB02 (lidocaine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Lidocaine · ATC N01BB02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Lidocaini hydrochloridum
Manufacturer
Chemische Fabrik Kreussler Co.GmbH
Country
Poland (PL)
ATC code
N01BB02
ATC class
Lidocaine
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991231903

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

671 interactions on record for lidocaine.

Graded by severity as the source publishes them — 13 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lidocaine · interactions on record

671 records

  • 13 severe
  • 206 moderate
  • 79 minor
  • 373 info

Most severe, free to view

  • DofetilideC01BD04severe
  • ArbutamineC01CA22severe
  • ConivaptanC03XA02severe
  • SaquinavirJ05AE01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lidocaine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lidocaine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Cathejell, Dynexan
  • Belgium · Instillido, Lidocaine Aguettant
  • Bulgaria · Instillido, Lidocaine Hydrochloride Monohydrate Чайкафарма
  • Cyprus · Lidocaine Apta, Lidocaine Hydrochloride Noridem
  • Czechia · Lidocain Egis, Lidocaine Egis
  • Germany · Acoin, Actilogic
  • Denmark · Instillido, Lidbree
  • Estonia · Instillido, Lidocaine Accord
  • Spain · Actilogic, Dermovagisil
  • Finland · Esliva, Instillido
  • France · Chlorhydrate De Lidocaine Renaudin, Dynexan
  • United Kingdom (Northern Ireland) · Boots Severe Sore Throat Relief, Chloradirect Severe Sore Throat Relief
  • Greece · Carmelido, Consolid
  • Croatia · Dolokain, Instillido
  • Hungary · Lidocain Egis, Lidocain-Egis
  • Ireland · Dolocopin, Lidocaine Hydrochloride
  • Iceland · Lidocaine Grindeks, Lidokain Viatris
  • Italy · Asensil, Basicaina
  • Liechtenstein · Lidocain Walter Ritter
  • Lithuania · Instillido, Lidocain-Egis
  • Luxembourg · Dynexan Gel, Lidocain Braun
  • Latvia · Lidocaine Baxter, Lidocaine Egis
  • Malta · Lidocaine Hydrochloride Bp B. Braun Melsungen, Lidonostrum
  • Netherlands · Dynexan Mondgel, Instillido
  • Norway · Instillido, Lidocaine Accord
  • Portugal · Lambdalina, Lidbree
  • Romania · Instillido, Lidocain
  • Sweden · Instillagel, Instillido
  • Slovenia · Instillido, Lidokain Kabi
  • Slovakia · Lidocain Egis, Lidocaine Noridem

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f6799217-9d18-475f-90df-bc3b7c86e41a
GET /v1/drugs/f6799217-9d18-475f-90df-bc3b7c86e41a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Żel do stosowania w jamie ustnej",
  "source": "urpl",
  "strength": "20 mg/g",
  "packaging": "05909991231903 ¦ OTC ¦ 109991\n1 tuba 10 g",
  "substance": "Lidocaini hydrochloridum 20 mg/g",
  "common_name": "Lidocaini hydrochloridum",
  "pl_product_id": "100350300",
  "pozwolenie_nr": "22593",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about lidocaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.